This paper was published through Galoá and has a deposited DOI. To cite this paper, use one of the standards below:
In case you are one of the co-authors and want to register this paper in your Lattes, use the following code: doi > 10.17648/bctrims-2023-167492
If you've NEVER registered a DOI in your Lattes, check our tutorial!Case Presentation: A 37-year-old black female patient presented with subacute loss of vision in both eyes, which began after the discontinuation of immunosuppressive treatment for Crohn's disease. Seven months after her vision loss, the optical exam revealed counting fingers visual acuity in both eyes and optic disc edema. Orbital MRI showed a longitudinally extensive lesion in the left optic nerve throughout the intraorbital segment of the nerve up to the optic canal. Brain MRI showed only small T2/FLAIR hyperintense lesions ("small patches"). A second follow-up exam, one and a half years after the vision loss, showed finger counting visual acuity in both eyes and optic disc atrophy. A new orbital MRI revealed bilateral optic nerve thinning without new brain abnormalities. Discussion: Crohn's disease is a chronic idiopathic inflammatory disease of the gastrointestinal tract that can present with extraintestinal symptoms, including optic neuritis (ON), which is a rare complication of Crohn's disease. The present case demonstrates that ON can occur following the discontinuation of inflammatory bowel disease treatment, suggesting a reactivation of autoimmune response. Although rare, ON can be bilateral and longitudinally extensive, leading to a poor functional prognosis, with significant impact on the patient's quality of life. Therefore, it is important to closely monitor patients with Crohn's disease, even after treatment discontinuation, to promptly identify and manage potential complications. Final Comments: Optic neuritis is rarely associated with Crohn's disease. This case report demonstrates that optic neuritis can (1) occur after the discontinuation of inflammatory bowel disease treatment, suggesting reactivation of autoimmune response; (2) be bilateral and longitudinally extensive; and (3) have a poor functional prognosis.
With nearly 200,000 papers published, Galoá empowers scholars to share and discover cutting-edge research through our streamlined and accessible academic publishing platform.
Learn more about our products:
This proceedings is identified by a DOI , for use in citations or bibliographic references. Attention: this is not a DOI for the paper and as such cannot be used in Lattes to identify a particular work.
Check the link "How to cite" in the paper's page, to see how to properly cite the paper